Su1751 ACHIEVEMENT OF CORTICOSTEROID-FREE CLINICAL, ENDOSCOPIC, AND HISTOLOGIC OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH RISANKIZUMAB: RESULTS FROM THE COMMAND STUDY

Gastroenterology(2024)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要